Literature DB >> 20412103

Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis.

Josef Sýkora1, Konrad Siala, Michal Huml, Jana Varvařovská, Jan Schwarz, Renáta Pomahačová.   

Abstract

AIM: The aim of the study is to evaluate faecal calprotectin (f-CP) in children ≤3 years of age with acute gastroenteritis (AG) as an early predictor of bacterial inflammation.
METHODS: We prospectively analysed f-CP levels and diagnostic workup in 107 consecutive children (66 AG, 41 controls).
RESULTS: Children with bacterial AG (BAG) was found to have higher diarrheal frequency (p < 0.01), fever (p < 0.01), erythrocyte sedimentation rate (p < 0.001), white blood count (p < 0.01) and C-reactive protein (CRP) (p < 0.001) compared with viral AG (VAG). Vomiting was frequent in VAG (p < 0.001). f-CP negatively correlated with age in controls (r = -0.5998). BAG demonstrated significantly higher f-CP levels [median, 219 μg/g, interquartile range (IQR): 119-350.2] compared with VAG (49.3 μg/g, IQR: 8.8-131.1) as well as controls (26.5 μg/g, IQR: 14.9-55.1) (p < 0.001). VAG and control f-CP levels were similar. f-CP was the best-rated marker of BAG with a diagnostic accuracy of 92%. Receiver-operator characteristic analysis revealed an area under curve of 0.95 for identifying BAG; sensitivity and specificity of f-CP were 93% and 88%, respectively, at an adjusted cut-off point of 103.9 μg/g faeces. Combined f-CP and CRP yield improved diagnostic accuracy of 94% for BAG.
CONCLUSION: f-CP facilitates early discrimination between bacterial and viral causes of AG in young children. Combining f-CP with CRP increases the diagnostic power of diagnosing BAG.
© 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412103     DOI: 10.1111/j.1651-2227.2010.01843.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  17 in total

1.  Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island.

Authors:  Marisol Garzón; Luis Pereira-da-Silva; Jorge Seixas; Ana Luísa Papoila; Marta Alves; Filipa Ferreira; Ana Reis
Journal:  Pathog Glob Health       Date:  2017-03-10       Impact factor: 2.894

Review 2.  Practical guidance on the use of faecal calprotectin.

Authors:  Matthew J Brookes; Simon Whitehead; Daniel R Gaya; Antony Barney Hawthorne
Journal:  Frontline Gastroenterol       Date:  2017-02-22

Review 3.  Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice.

Authors:  Eliza Lężyk-Ciemniak; Magdalena Tworkiewicz; Dominika Wilczyńska; Anna Szaflarska-Popławska; Aneta Krogulska
Journal:  Med Princ Pract       Date:  2020-10-29       Impact factor: 1.927

4.  Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial.

Authors:  Anke Heida; Alie Dijkstra; Henk Groen; Anneke Muller Kobold; Henkjan Verkade; Patrick van Rheenen
Journal:  Trials       Date:  2015-06-16       Impact factor: 2.279

5.  Comparison of fecal pyruvate kinase isoform M2 and calprotectin in acute diarrhea in hospitalized children.

Authors:  Elzbieta Czub; Jan K Nowak; Jerzy Moczko; Aleksandra Lisowska; Aleksandra Banaszkiewicz; Tomasz Banasiewicz; Jaroslaw Walkowiak
Journal:  Sci Rep       Date:  2014-04-24       Impact factor: 4.379

6.  Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Maria Jose Sandi; Susana Pinó Donnay; Teddy Grandjean; Maria Pellisé; Julián Panés; Elena Ricart; Juan Lucio Iovanna; Jean-Charles Dagorn; Mathias Chamaillard; Miquel Sans
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

7.  Fecal calprotectin concentrations in healthy children aged 1-18 months.

Authors:  Feng Li; Jingqiu Ma; Shanshan Geng; Junli Wang; Jinrong Liu; Jie Zhang; Xiaoyang Sheng
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

Review 8.  Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review.

Authors:  Anokhi J Kapasi; Sabine Dittrich; Iveth J González; Timothy C Rodwell
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 9.  Fecal biomarkers of intestinal health and disease in children.

Authors:  Tamara Pang; Steven T Leach; Tamarah Katz; Andrew S Day; Chee Y Ooi
Journal:  Front Pediatr       Date:  2014-01-28       Impact factor: 3.418

10.  Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.

Authors:  Avi Peretz; Linda Tkhawkho; Nina Pastukh; Diana Brodsky; Chen Namimi Halevi; Orna Nitzan
Journal:  BMC Infect Dis       Date:  2016-06-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.